Cholesterol Medication Debate

Dave and Simon discuss the impact of excluding individuals on cholesterol-lowering medication from studies, highlighting potential confounders like non-adherence and healthy user bias. The conversation delves into the complexities of interpreting data and the limitations of post hoc analysis.